Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs

MDS

Fred Hutchinson Cancer CenterCell therapyPhase 2/3Active

BB

66/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 58/ 100
Competitive Position: 81/ 100

Competitive context

314 Active assets in the MDS cohort.

Asset / Sponsor	Phase	Rating
Fludarabine Sawa Ito, MD	Phase 4	BB
Cyclophosphamide Sawa Ito, MD	Phase 4	BB
Daunorubicin OHSU Knight Cancer Institute	Phase 3	BB
FILGRASTIM City of Hope Medical Center	Phase 4	BB
Anti-Thymoglobulin, Rabbit Peking University First Hospital	Phase 2/3	BB

View all 50 →

Same molecule, other indications

Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs is also rated in:

acute lymphoblastic leukemiaDormant

BBB

Indicative ·

74 / 100

Acute Myelogenous LeukemiaDormant

BB

Indicative ·

70 / 100

Myelodysplastic SyndromesDormant

BB

Indicative ·

68 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.